Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002065881-25-000028
Filing Date
2025-06-16
Accepted
2025-06-16 20:17:58
Documents
3
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750119471.html 4  
1 FORM 4 wk-form4_1750119471.xml 4 6125
2 EX-24.1 welguspowerofattorney.htm EX-24.1 4314
3 welguspowerofattorney001.jpg GRAPHIC 256651
  Complete submission text file 0002065881-25-000028.txt   365621
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD, SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address
Welgus Howard G. (Reporting) CIK: 0001801050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 251051624